Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathy
Johanna C. Herkert(University Medical Center Groningen), Jan D.H. Jongbloed(University Medical Center Groningen), Irene M. van Langen, Erwin Birnie(Leiden University), Gideon J. du Marchie Sarvaas(Oslo University Hospital), Paul A. van der Zwaag(University Medical Center Groningen), Maarten P. van den Berg(Regions Hospital), Richard J. Sinke(University Medical Center Utrecht), Daniela Q.C.M. Barge‐Schaapveld(Leiden University), J. Peter van Tintelen(Utrecht University), Yvonne J. Vos(University Medical Center Groningen), Marloes Benjamins(University Medical Center Groningen), Martine T. Meems-Veldhuis(University Medical Center Groningen), Ludolf G. Boven(University Medical Center Groningen), Kristin M. Abbott(National Health Service)
Cited by 46
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
|Journal of the American College of Cardiology|2012|519
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2010|485
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
|European Heart Journal|2013|396
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands
|The American Journal of Human Genetics|2019|378